To include your compound in the COVID-19 Resource Center, submit it here.

Catena idebenone regulatory update

Santhera said FDA granted rare pediatric disease designation to idebenone to treat Duchenne muscular

Read the full 149 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE